ThomasJosephSferraMD

Pediatric Gastroenterology • Cleveland, OH

Associate Professor of Pediatrics, Case Western Reserve University School of Medicine, UH Rainbow Babies & Children's Hospital

Join to view full profile

Dr. Sferra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sferra's full profile

Already have an account?

Office
11100 Euclid Ave
Cleveland, OH 44106
Phone+1 216-844-7700

Education & Training

Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 1986 - 1989
Northeast Ohio Medical UniversityClass of 1986

Certifications & Licensure

OH State Medical License 1987 - 2026
FL State Medical License 2019 - 2021
OK State Medical License 2006 - 2012
MI State Medical License 1990 - 1994
American Board of Pediatrics Pediatric Gastroenterology

Awards, Honors, & Recognition

Oklahoma Magazine Castle Connolly, 2008-2012

Clinical Trials

Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children Start of enrollment: 2020 Aug 28
Recruiting
Phase 2
Roles: Contact, Principal Investigator
A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old Start of enrollment: 2023 Feb 20
RECRUITING
PHASE2
Roles: Principal Investigator
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old Start of enrollment: 2023 May 23
RECRUITING
PHASE2
Roles: Principal Investigator
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) Start of enrollment: 2022 Apr 30
RECRUITING
PHASE3
Roles: Principal Investigator
A Study of Vedolizumab in Children and Teenagers with Moderate to Severe Ulcerative Colitis (UC) Start of enrollment: 2022 Apr 18
ACTIVE_NOT_RECRUITING
PHASE3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Downregulating FGGY carbohydrate kinase domain containing promotes cell senescence by activating the p53/p21 signaling pathway in colorectal cancer.
Liya Liu, Meizhu Wu, Youqin Chen, Ying Cheng, Sijia Liu
International Journal of Molecular Medicine. 2025-05-01
1 citations
Qing Hua Chang Yin ameliorates chronic colitis in mice by inhibiting PERK-ATF4-CHOP pathway of ER stress and the NF-κB signalling pathway.
Liya Liu, Youqin Chen, Yuying Han, Xinran Zhang, Yulun Wu
Pharmaceutical Biology. 2024-12-01
miR-326 overexpression inhibits colorectal cancer cell growth and proteasome activity by targeting PNO1: unveiling a novel therapeutic intervention strategy.
Yi Fang, Yulun Wu, Xinran Zhang, Lihui Wei, Liya Liu
Scientific Reports. 2024-10-16

Journal Articles

Are We Going Nuts on Coconut Oil?
Thomas Sferra, MD, Current Nutrition Reports

Press Mentions

12 GI Physicians Featured in JulyJuly 31st, 2019
GI Salary, Revenue Generated & Demand: 3 Notes from Merritt HawkinsJuly 23rd, 2019
GI Leader to Know: Dr. Thomas Sferra of Rainbow Babies & Children’s HospitalJuly 22nd, 2019

Grant Support

Gene Therapy For Lysosomal Storage DiseaseNational Institute Of Neurological Disorders And Stroke2000–2003